Regulation of physical microglia–neuron interactions by fractalkine signaling after status epilepticus

eNeuro

Volumn 3, Issue 6, 2016, Pages

  Eyo, Ukpong B ^a,b   Peng, Jiyun ^a,b   Murugan, Madhuvika ^a,b   Mo, Mingshu ^a,c   Lalani, Almin ^a   Xie, Ping ^a   Xu, Pingyi ^c   Margolis, David J ^a   Wu, Long Jun ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b Mayo Clinic   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Epilepsy; Fractalkine; Glutamate; Interleukin 1 ; Microglia; Seizure

Indexed keywords

CARBENOXOLONE; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; GLUTAMIC ACID; INTERLEUKIN 1BETA; AMINO ACID RECEPTOR STIMULATING AGENT; CHEMOKINE RECEPTOR CXCR1; CX3CL1 PROTEIN, MOUSE; IL1B PROTEIN, MOUSE; KAINIC ACID; P2RY12 PROTEIN, MOUSE; PILOCARPINE; PURINERGIC P2Y12 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; EPILEPTIC STATE; FEMALE; MALE; MICROGLIA; MOUSE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEIZURE; ANIMAL; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE; TRANSGENIC MOUSE;

ANIMALS; CHEMOKINE CX3CL1; EXCITATORY AMINO ACID AGONISTS; FEMALE; GLUTAMIC ACID; INTERLEUKIN-1BETA; KAINIC ACID; MALE; MICE, TRANSGENIC; MICROGLIA; NEURONS; NEUROPROTECTION; PILOCARPINE; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, PURINERGIC P2Y12; SEIZURES; STATUS EPILEPTICUS; TISSUE CULTURE TECHNIQUES;

EID: 85021413098     PISSN: None     EISSN: 23732822     Source Type: Journal    
DOI: 10.1523/ENEURO.0209-16.2016     Document Type: Article

References (60)

1. Avignone E, Ulmann L, Levavasseur F, Rassendren F, Audinat E (2008) Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. J Neurosci 28: 9133–9144.
2. Baalman K, Marin MA, Ho TS, Godoy M, Cherian L, Robertson C, Rasband MN (2015) Axon initial segment-associated microglia. J Neurosci 35: 2283–2292.
3. Ban E, Milon G, Prudhomme N, Fillion G, Haour F (1991) Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 43: 21–30.
4. Ban EM (1994) Interleukin-1 receptors in the brain: characterization by quantitative in situ autoradiography. Immunomethods 5: 31–40.
5. Ben Achour S, Pascual O (2012) Astrocyte-neuron communication: functional consequences. Neurochem Res 37: 2464–2473.
6. Bikson M, Ghai RS, Baraban SC, Durand DM (1999) Modulation of burst frequency, duration, and amplitude in the zero-Ca (2+) model of epileptiform activity. J Neurophysiol 82: 2262–2270.
7. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Littman DR, Ransohoff RM (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9: 917–924.
8. Cavus I, Kasoff WS, Cassaday MP, Jacob R, Gueorguieva R, Sherwin RS, Krystal JH, Spencer DD, Abi-Saab WM (2005) Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann Neurol 57: 226–235.
9. Cavus I, Pan JW, Hetherington HP, Abi-Saab W, Zaveri HP, Vives KP, Krystal JH, Spencer SS, Spencer DD (2008) Decreased hippocampal volume on MRI is associated with increased extracellular glutamate in epilepsy patients. Epilepsia 49: 1358–1366.
10. Chapman GA, Moores K, Harrison D, Campbell CA, Stewart BR, Strijbos PJ (2000) Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J Neurosci 20: RC87.
11. Chen Q, Cichon J, Wang W, Qiu L, Lee SJ, Campbell NR, Destefino N, Goard MJ, Fu Z, Yasuda R, Looger LL, Arenkiel BR, Gan WB, Feng G (2012) Imaging neural activity using Thy1-GCaMP transgenic mice. Neuron 76: 297–308.
12. Clark AK, Gruber-Schoffnegger D, Drdla-Schutting R, Gerhold KJ, Malcangio M, Sandkühler J (2015) Selective activation of microglia facilitates synaptic strength. J Neurosci 35: 4552–4570.
13. Dalby NO, Mody I (2001) The process of epileptogenesis: a pathophysiological approach. Curr Opin Neurol 14: 187–192.
14. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8: 752–758.
15. Dénes A, Ferenczi S, Halász J, Környei Z, Kovécs KJ (2008) Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J Cereb Blood Flow Metab 28: 1707–1721.
16. Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA (2013) Glia and epilepsy: excitability and inflammation. Trends Neurosci 36: 174–184.
17. Dissing-Olesen L, LeDue JM, Rungta RL, Hefendehl JK, Choi HB, MacVicar BA (2014) Activation of neuronal NMDA receptors triggers transient ATP-mediated microglial process outgrowth. J Neurosci 34: 10511–10527.
18. Eriksson C, Zou LP, Ahlenius S, Winblad B, Schultzberg M (2000) Inhibition of kainic acid induced expression of interleukin-1 beta and interleukin-1 receptor antagonist mRNA in the rat brain by NMDA receptor antagonists. Brain Res Mol Brain Res 85: 103–113.
19. Eriksson C, Van Dam AM, Lucassen PJ, Bol JG, Winblad B, Schultzberg M (1999) Immunohistochemical localization of interleukin-1beta, interleukin-1 receptor antagonist and interleukin-1beta converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid. Neuroscience 93: 915–930.
20. Eyo UB, Murugan M, Wu LJ (2016) Microglia-neuron communication in epilepsy. Glia 65: 5–18.
21. Eyo UB, Peng J, Swiatkowski P, Mukherjee A, Bispo A, Wu LJ (2014) Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus. J Neurosci 34: 10528–10540.
22. Eyo UB, Gu N, De S, Dong H, Richardson JR, Wu LJ (2015) Modulation of microglial process convergence toward neuronal dendrites by extracellular calcium. J Neurosci 35: 2417–2422.
23. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28: 41–51.
24. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J Jr. (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46: 470–472.
25. Hanisch UK, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387–1394.
26. Heinemann U, Konnerth A, Pumain R, Wadman WJ (1986) Extracellular calcium and potassium concentration changes in chronic epileptic brain tissue. Adv Neurol 44: 641–661.
27. Honda S, Sasaki Y, Ohsawa K, Imai Y, Nakamura Y, Inoue K, Kohsaka S (2001) Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci 21: 1975–1982.
28. Jander S, Schroeter M, Stoll G (2000) Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia. J Neuroimmunol 109: 181–187.
29. Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D, Green P, Fleshner M, Leinwand L, Maier SF, Watkins LR (2004) A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 24: 7353–7365.
30. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR (2000) Analysis of fractalkine receptor CX (3) CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20: 4106–4114.
31. Kato G, Inada H, Wake H, Akiyoshi R, Miyamoto A, Eto K, Ishikawa T, Moorhouse AJ, Strassman AM, Nabekura J (2016) Microglial contact prevents excess depolarization and rescues neurons from excitotoxicity. eNeuro 3: 0004.16.
32. Konnerth A, Heinemann U, Yaari Y (1986) Nonsynaptic epileptogenesis in the mammalian hippocampus in vitro. I. Development of seizurelike activity in low extracellular calcium. J Neurophysiol 56: 409–423.
33. Kwan P, Brodie MJ (2006) Refractory epilepsy: mechanisms and solutions. Expert Rev Neurother 6: 397–406.
34. Li Y, Du XF, Liu CS, Wen ZL, Du JL (2012) Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo. Dev Cell 23: 1189–1202.
35. Limatola C, Ransohoff RM (2014) Modulating neurotoxicity through CX3CL1/CX3CR1 signaling. Front Cell Neurosci 8: 229.
36. Maggi L, Scianni M, Branchi I, D’Andrea I, Lauro C, Limatola C (2011) CX (3) CR1 deficiency alters hippocampal-dependent plasticity phenomena blunting the effects of enriched environment. Front Cell Neurosci 5: 22.
37. Noda M, Doi Y, Liang J, Kawanokuchi J, Sonobe Y, Takeuchi H, Mizuno T, Suzumura A (2011) Fractalkine attenuates excitoneurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression. J Biol Chem 286: 2308–2319.
38. Paolicelli RC, Bisht K, Tremblay ME (2014) Fractalkine regulation of microglial physiology and consequences on the brain and behavior. Front Cell Neurosci 8: 129.
39. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281–294.
40. Ransohoff RM, Perry VH (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27: 119–145.
41. Ravizza T, Balosso S, Vezzani A (2011) Inflammation and prevention of epileptogenesis. Neurosci Lett 497: 223–230.
42. Rogers JT, Morganti JM, Bachstetter AD, Hudson CE, Peters MM, Grimmig BA, Weeber EJ, Bickford PC, Gemma C (2011) CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci 31: 16241–16250.
43. Sharma AK, Reams RY, Jordan WH, Miller MA, Thacker HL, Snyder PW (2007) Mesial temporal lobe epilepsy: pathogenesis, induced rodent models and lesions. Toxicol Pathol 35: 984–999.
44. Sperlágh B, Baranyi M, Haskó G, Vizi ES (2004) Potent effect of interleukin-1 beta to evoke ATP and adenosine release from rat hippocampal slices. J Neuroimmunol 151: 33–39.
45. Tang Z, Gan Y, Liu Q, Yin JX, Liu Q, Shi J, Shi FD (2014) CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/ macrophage in experimental ischemic stroke. J Neuroinflammation 11: 26.
46. Temkin NR (2009) Preventing and treating posttraumatic seizures: the human experience. Epilepsia 50: Suppl 2: 10–13.
47. Thurman DJ, et al. (2011) Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 52: Suppl 7: 2–26.
48. Torres A, Wang F, Xu Q, Fujita T, Dobrowolski R, Willecke K, Takano T, Nedergaard M (2012) Extracellular Ca (2) (+) acts as a mediator of communication from neurons to glia. Sci Signal 5: ra8.
49. Tremblay ME, Lowery RL, Majewska AK (2010) Microglial interactions with synapses are modulated by visual experience. PLoS Biol 8: e1000527.
50. Vezzani A, Viviani B (2014) Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology 96 (Pt A): 70-82.
51. Vezzani A, Balosso S, Ravizza T (2008a) The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22: 797–803.
52. Vezzani A, Ravizza T, Balosso S, Aronica E (2008b) Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 49: Suppl 2: 24–32.
53. Vezzani A, Aronica E, Mazarati A, Pittman QJ (2013) Epilepsy and brain inflammation. Exp Neurol 244: 11–21.
54. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG (1999) Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 19: 5054-5065.
55. Wadman WJ, Heinemann U, Konnerth A, Neuhaus S (1985) Hippocampal slices of kindled rats reveal calcium involvement in epileptogenesis. Exp Brain Res 57: 404–407.
56. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J (2009) Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 29: 3974–3980.
57. Wang S, Cheng Q, Malik S, Yang J (2000) Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA (A)) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther 292: 497–504.
58. Wu LJ, Vadakkan KI, Zhuo M (2007) ATP-induced chemotaxis of microglial processes requires P2Y receptor-activated initiation of outward potassium currents. Glia 55: 810–821.
59. Xiao F, Xu JM, Jiang XH (2015) CX3 chemokine receptor 1 deficiency leads to reduced dendritic complexity and delayed maturation of newborn neurons in the adult mouse hippocampus. Neural Regen Res 10: 772–777.
60. Zhan Y, Paolicelli RC, Sforazzini F, Weinhard L, Bolasco G, Pagani F, Vyssotski AL, Bifone A, Gozzi A, Ragozzino D, Gross CT (2014) Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat Neurosci 17: 400–406.